Pyrimidine compounds for the inhibition of Eph receptors and for the treatment of cancer
Disclosed is a compound of Formula I wherein one of A1,A2 or A3 is N, and the others are independently selected from CH or N; R1 is a (1-4C)alkyl group which is optionally substituted by one or more substituent groups selected from -OR5 (wherein R5 is selected from hydrogen or (1-2C)alkyl), cyano, h...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
24.02.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed is a compound of Formula I wherein one of A1,A2 or A3 is N, and the others are independently selected from CH or N; R1 is a (1-4C)alkyl group which is optionally substituted by one or more substituent groups selected from -OR5 (wherein R5 is selected from hydrogen or (1-2C)alkyl), cyano, halo, or ?NR6R7 (where R6 and R7 are independently selected from hydrogen, (1-2C)alkyl or (1?2C)alkanoyl); n is 0, 1, 2 or 3; each R2 group present is independently selected from (1-2C)alkyl, (1-2C)alkoxy, fluoro, chloro, cyano, hydroxy(1-2C)alkyl, or a group of sub-formula: -Q-R8 Specific examples of a compound of Formula I include N'-(3-chloro-2,4-difluoro-phenyl)-N-(4-chloro-6-morpholin-4-yl-pyridin-2-yl)-N'-methylpyrimidine- 2,4-diamine, and N'-(3-chloro-2,4-difluoro-phenyl)-N-(2,6-dimorpholin-4-ylpyridin-4-yl)-N'-methylpyrimidine-2,4-diamine; Also disclosed is the use of the compound of Formula I for treating cancer. |
---|---|
AbstractList | Disclosed is a compound of Formula I wherein one of A1,A2 or A3 is N, and the others are independently selected from CH or N; R1 is a (1-4C)alkyl group which is optionally substituted by one or more substituent groups selected from -OR5 (wherein R5 is selected from hydrogen or (1-2C)alkyl), cyano, halo, or ?NR6R7 (where R6 and R7 are independently selected from hydrogen, (1-2C)alkyl or (1?2C)alkanoyl); n is 0, 1, 2 or 3; each R2 group present is independently selected from (1-2C)alkyl, (1-2C)alkoxy, fluoro, chloro, cyano, hydroxy(1-2C)alkyl, or a group of sub-formula: -Q-R8 Specific examples of a compound of Formula I include N'-(3-chloro-2,4-difluoro-phenyl)-N-(4-chloro-6-morpholin-4-yl-pyridin-2-yl)-N'-methylpyrimidine- 2,4-diamine, and N'-(3-chloro-2,4-difluoro-phenyl)-N-(2,6-dimorpholin-4-ylpyridin-4-yl)-N'-methylpyrimidine-2,4-diamine; Also disclosed is the use of the compound of Formula I for treating cancer. |
Author | DUCRAY, RICHARD BARLAAM, BERNARD, CHRISTOPHE |
Author_xml | – fullname: DUCRAY, RICHARD – fullname: BARLAAM, BERNARD, CHRISTOPHE |
BookMark | eNqFyj0KAjEQBtAUWvh3BZkLWMgiaimyYiUWFmKzxORbdsCdCclYeHsRxNbqNW_sBqKCkbueX5l7jiygoH3Sp8RCrWayDsTS8Z2NVUhbqlNHGQHJNBfyEn_PMrz1EPu04CUgT92w9Y-C2deJmx_qy_64QNIGJfkAgTWn22qzrLbrXfU3vAGCbDrn |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | NZ581397A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_NZ581397A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:58:16 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_NZ581397A3 |
Notes | Application Number: NZ20080581397 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120224&DB=EPODOC&CC=NZ&NR=581397A |
ParticipantIDs | epo_espacenet_NZ581397A |
PublicationCentury | 2000 |
PublicationDate | 20120224 |
PublicationDateYYYYMMDD | 2012-02-24 |
PublicationDate_xml | – month: 02 year: 2012 text: 20120224 day: 24 |
PublicationDecade | 2010 |
PublicationYear | 2012 |
RelatedCompanies | ASTRAZENECA AB |
RelatedCompanies_xml | – name: ASTRAZENECA AB |
Score | 2.830179 |
Snippet | Disclosed is a compound of Formula I wherein one of A1,A2 or A3 is N, and the others are independently selected from CH or N; R1 is a (1-4C)alkyl group which... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Pyrimidine compounds for the inhibition of Eph receptors and for the treatment of cancer |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120224&DB=EPODOC&locale=&CC=NZ&NR=581397A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR3LasJAcLC2tL219v2QPZTcQqPZGD2EUpOIFIyh2CJeZNesj0sMJqX07zuzRNuLt2V3GHZnmdfuPACenKbrOm7HMi3Fucml7ZodW1hmWzoCxWHidAQ5ioOo1f_gb2NnXIHFNhdG1wn91sURkaNmyO-FltfZ3yNWoGMr82e5wqn1S2_kBUbpHTeapJKMoOuF8TAY-obve9HEiN49p02mzusBHJINTUX2w88upaRk__VJ7wyOYkSVFudQUWkNTvxt27UaHA_K324cloyXX8A4_qH-W6hoFKMocGqGlDM0OBkacGyVLldSx16x9ZyF2ZKhHFMZNdJhIk12cLuocgKb0X1vLqHeC0d-38QtTnfEmEaT8ij2FVTTdapugEkrSdDPnbe45Fy0hbAaCik9a7aUbfNE3cL1HiR3e1fu4ZToqbO3-QNUi82XekT9W8i6pt0v4YKMPA |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdR1NT8Iw9AXRiDdFxU_swey2OFjH4LAY2SCoMIhBQ7iQlhXhMhaYMf5732sGeuHWtC8v7WveV_s-AO6dqus6bsMyLcW5yaXtmg1bWGZdOgLFYeQ0BDmKvbDWeecvI2eUg89NLoyuE_qtiyMiR02R31Mtr5O_R6xAx1auH-QCp5aP7aEXGJl3XKmSSjKCptca9IO-b_i-F46N8M1z6mTqPO3Bvkuleclu-mhSSkryX5-0j-FggKji9ARyKi5Cwd-0XSvCYS_77cZhxnjrUxgNfqj_FioaxSgKnJohrRkanAwNOLaI5wupY6_YcsZayZyhHFMJNdJhIo62cNuocgKb0n2vzqDcbg39jolbnGyJMQnH2VHsc8jHy1hdAJNWFKGfO6txybmoC2FVFFJ6Wq0p2-aRuoTSDiRXO1fuoNAZ9rqT7nP4eg1HRFudyc1vIJ-uvtQt6uJUljUdfwGZqI8p |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pyrimidine+compounds+for+the+inhibition+of+Eph+receptors+and+for+the+treatment+of+cancer&rft.inventor=DUCRAY%2C+RICHARD&rft.inventor=BARLAAM%2C+BERNARD%2C+CHRISTOPHE&rft.date=2012-02-24&rft.externalDBID=A&rft.externalDocID=NZ581397A |